O'Keeffe Aidan G, Nazareth Irwin, Petersen Irene
Department of Statistical Science, University College London, London, UK.
Department of Primary Care and Population Health, University College London, London, UK.
Clin Epidemiol. 2016 May 27;8:123-32. doi: 10.2147/CLEP.S104258. eCollection 2016.
Statins are widely prescribed for the primary prevention of cardiovascular disease. Guidelines exist for statin prescriptions, but there is little recent analysis concerning prescription trends over time and how these vary with respect to demographic variables.
Using The Health Improvement Network primary care database, statin therapy initiation and statin prescription prevalence rates were calculated using data from 7,027,711 individuals across the UK for the years 1995 to 2013, overall and stratified by sex, age group, and socioeconomic deprivation level (Townsend score). Statin therapy initiation rates rose sharply from 1995 (0.51 per 1,000 person-years) up to 2006 (19.83 per 1,000 person-years) and thereafter declined (10.76 per 1,000 person-years in 2013). Males had higher initiation rates than females and individuals aged 60-85 years had higher initiation rates than younger or more elderly age groups. Initiation rates were slightly higher as social deprivation level increased, after accounting for age and sex. Prescription prevalence increased sharply from 1995 (2.36 per 1,000 person-years) to 2013 (128.03 per 1,000 person-years) with males generally having a higher prevalence rate, over time, than females. Prevalence rates over time were generally higher for older age groups but were similar with respect to social deprivation level.
The uptake of statins within UK primary care has increased greatly over time with statins being more commonly prescribed to older patients in general and, in recent years, males appear to have been prescribed statins at higher rates than females. After accounting for age and sex, the statin therapy initiation rate increases with the level of social deprivation.
他汀类药物被广泛用于心血管疾病的一级预防。虽然存在他汀类药物处方指南,但近期关于随时间变化的处方趋势以及这些趋势如何随人口统计学变量而变化的分析较少。
利用健康改善网络初级保健数据库,通过对1995年至2013年英国7027711人的数据进行计算,得出他汀类药物治疗起始率和他汀类药物处方流行率,总体数据以及按性别、年龄组和社会经济剥夺水平(汤森得分)分层的数据。他汀类药物治疗起始率从1995年的每1000人年0.51急剧上升至2006年的每1000人年19.83,此后下降(2013年为每1000人年10.76)。男性的起始率高于女性,60 - 85岁的个体起始率高于年轻或更年长的年龄组。在考虑年龄和性别后,随着社会剥夺水平的增加,起始率略有升高。处方流行率从1995年的每1000人年2.36急剧增加到2013年的每1000人年128.03,总体而言,男性的流行率高于女性。随着时间推移,老年人群的流行率通常更高,但在社会剥夺水平方面相似。
随着时间的推移,英国初级保健中他汀类药物的使用大幅增加,总体上他汀类药物在老年患者中更常用,近年来,男性使用他汀类药物的处方率似乎高于女性,并在考虑年龄和性别后,他汀类药物治疗起始率随社会剥夺水平的升高而增加。